Esperite base_Aktie

Esperite base_Verbindlichkeiten 2025

Esperite base_Verbindlichkeiten

0 EUR

components_StockPageHeader__3

ESP.AS

components_StockPageHeader__4

NL0009272137

pages_kennzahlen_[key]_[isin]__52

Esperite Aktienanalyse

pages_kennzahlen_[key]_[isin]__1

Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite ist eines der beliebtesten Unternehmen auf Eulerpool.com.

pages_kennzahlen_[key]_[isin]__85

pages_kennzahlen_[key]_[isin]__79

pages_dividenden_[isin]_index__2

components_kpi_LiabilitiesFaqs_0

components_kpi_LiabilitiesFaqs_1

components_kpi_LiabilitiesFaqs_2

components_kpi_LiabilitiesFaqs_3

components_kpi_LiabilitiesFaqs_4

components_kpi_LiabilitiesFaqs_5

components_kpi_LiabilitiesFaqs_6

components_kpi_LiabilitiesFaqs_7

components_kpi_LiabilitiesFaqs_8

components_kpi_LiabilitiesFaqs_9

components_kpi_LiabilitiesFaqs_10

components_kpi_LiabilitiesFaqs_11

components_kpi_LiabilitiesFaqs_12

components_kpi_LiabilitiesFaqs_13

components_kpi_LiabilitiesFaqs_14

components_kpi_LiabilitiesFaqs_15

components_kpi_LiabilitiesFaqs_16

components_kpi_LiabilitiesFaqs_17

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Esperite kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

components_kpi_Savingsplan_0